July 7: The Week in Cancer News
Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.
Progress Against Cancer
Reducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
New treatments aim to lengthen remissions and push back recurrences.
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
Adoptive T-cell therapy shows promise in treating metastatic melanoma.
New oral hormonal therapy offers alternative to injections for some women with metastatic disease.
Hematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
AI has significant implications for medicine, especially for precision cancer care.
Childhood cancer survivors have a higher risk of developing depression and anxiety, and more news selected by the editors of Cancer Today.
According to an annual Gallup poll that surveys approximately 10,000 U.S. adults, 7.2% of Americans aged 18 and older identified as lesbian, gay, bisexual, transgender, queer, intersex, asexual, or anything other than heterosexual and...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More